News

Life sciences companies benefit from the ‘pharma carveout’ in Trump’s tariffs. But how long will it last?
The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...
Trump’s Next Tariffs Target Could Be Foreign-Made Medicines
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...
Potential Stock Woe Ahead as Pfizer (PFE) Riles Donald Trump
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
Hosted on MSN10d
Did pharma sector dodge Trump’s tariffs? The EU's not so sure
The industry had been bracing for impact since February, when Trump suggested imposing 25% tariffs on medicines. Among ...
inews.co.uk on MSN4d
Weight-loss jabs could face price rises and shortages due to Trump’s trade war
Trump’s latest tariff vow threatens to disrupt supplies of obesity drugs such as Mounjaro and Wegovy as pharma giants face ...
Barchart on MSN4d
Huge Unusual Trading in Pfizer Put Options Signals Investors' Bearish Outlook
Large, unusual trading volume in Pfizer Inc. (PFE) put options is accruing today, signaling a bearish outlook by ...
Trump tariffs could soften one of Europe’s most expensive housing markets—if Apple and Pfizer workers are hit with layoffs
Ireland’s complex, pricey housing market could face a downturn if Donald Trump’s trade war comes for the country’s well-paid ...
Trump’s Tariff Threat Sparks Race to Find US Drug Manufacturers
Drug manufacturers are rushing to reshape their supply chains amid President Donald Trump’s escalating tariff threats, ...